Medindia

X

Endo Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results

Friday, July 30, 2010 Drug News J E 4
Advertisement

Endo Pharmaceuticals Holdings Inc.

Condensed Consolidated Cash Flow Data (unaudited)

(in thousands)

Six Months EndedJune 30,

2010

2009

Net cash provided by operating activities

$  176,356

$  140,572

Net cash provided by (used in) investing activities

154,785

(424,758)

Net cash (used in) provided by financing activities

(47,332)

3,482

Net increase (decrease) in cash and cash equivalents

$  283,809

$  (280,704)

Cash and cash equivalents, beginning of period

$  708,462

$  775,693

Cash and cash equivalents, end of period

$  992,271

$  494,989

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Arcadia Resources Announces Webcast of its Fiscal ...
S
Volcano Reports Record Quarterly Revenues and Prof...